Evidence map›Paper›PMID 26232878›Full record

ArticleBiomaterials2015

Biodegradable, phosphate-containing, dual-gelling macromers for cellular delivery in bone tissue engineering.

Brendan M Watson, Tiffany N Vo, Alexander M Tatara, Sarita R Shah, David W Scott, Paul S Engel, Antonios G Mikos

Abstract read
In one paragraph

Article in Biomaterials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Reducing posttreatment relapse in cleft lip palatal expansion using an injectable estrogen-nanodiamond hydrogel.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Brendan M WatsonDepartment of Bioengineering, Rice University, Houston, TX 77030, USA.
Tiffany N VoDepartment of Bioengineering, Rice University, Houston, TX 77030, USA.
Alexander M TataraDepartment of Bioengineering, Rice University, Houston, TX 77030, USA.
Sarita R ShahDepartment of Bioengineering, Rice University, Houston, TX 77030, USA.
David W ScottDepartment of Statistics, Rice University, Houston, TX 77251, USA.
Paul S EngelDepartment of Chemistry, Rice University, Houston, TX 77251, USA.
Antonios G MikosDepartment of Bioengineering, Rice University, Houston, TX 77030, USA. Electronic address: mikos@rice.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007330 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PLON, SHARON E. · 1985 to 2019
$15.6M
Injectable Cellular Composites for Cartilage EngineeringR01AR048756 · NIAMS · RICE UNIVERSITY · PI KASPER, FRED KURTIS, MIKOS, ANTONIOS G. · 2003 to 2014
$3.3M
In Situ Hardening Cellular Constructs for Craniofacial Bone RegenerationR01DE017441 · NIDCR · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2008 to 2012
$1.6M
Nanobiology Interdisciplinary Graduate Training ProgramT32EB009379 · NIBIB · RICE UNIVERSITY · PI DREZEK, REBEKAH A. · 2009 to 2013
$1.6M
NIAMS NIH HHS R01 AR048756NIAMS NIH HHS R01 AR48756NIBIB NIH HHS T32 EB009379NIDCR NIH HHS R01 DE017441NIDCR NIH HHS R01 DE17441NIGMS NIH HHS T32 GM007330
6 · The paper itself

Abstract

Injectable, biodegradable, dual-gelling macromer solutions were used to encapsulate mesenchymal stem cells (MSCs) within stable hydrogels when elevated to physiologic temperature. Pendant phosphate groups were incorporated in the N-isopropyl acrylamide-based macromers to improve biointegration and facilitate hydrogel degradation. The MSCs were shown to survive the encapsulation process, and live cells were detected within the hydrogels for up to 28 days in vitro. Cell-laden hydrogels were shown to undergo significant mineralization in osteogenic medium. Cell-laden and acellular hydrogels were implanted into a critical-size rat cranial defect for 4 and 12 weeks. Both cell-laden and acellular hydrogels were shown to degrade in vivo and help to facilitate bone growth into the defect. Improved bone bridging of the defect was seen with the incorporation of cells, as well as with higher phosphate content of the macromer. Furthermore, direct bone-to-hydrogel contact was observed in the majority of implants, which is not commonly seen in this model. The ability of these macromers to deliver stem cells while forming in situ and subsequently degrade while facilitating bone ingrowth into the defect makes this class of macromers a promising material for craniofacial bone tissue engineering.

Indexed as

Alkaline PhosphataseAnimalsBiocompatible MaterialsBone and BonesCalciumDNAHydrogelsMaleMesenchymal Stem CellsMicroscopy, ConfocalPhosphatesPolymersRats, Inbred F344Tissue EngineeringTissue ScaffoldsX-Ray MicrotomographyAlkaline PhosphataseBiocompatible MaterialsCalciumDNAHydrogelsPhosphatesPolymersHydrogelMesenchymal stem cell encapsulationMonoacryloxyethyl phosphatePoly(N-isopropyl acrylamide)Rat cranial defect

Identifiers

PMID26232878
PMCPMC4550499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.